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Key role of splenic myeloid DCs in the IFN-alphabeta response
to adenoviruses in vivo
Abstract
The early systemic production of interferon (IFN)-alphabeta is an essential component of the antiviral
host defense mechanisms, but is also thought to contribute to the toxic side effects accompanying gene
therapy with adenoviral vectors. Here we investigated the IFN-alphabeta response to human
adenoviruses (Ads) in mice. By comparing the responses of normal, myeloid (m)DC- and plasmacytoid
(p)DC-depleted mice and by measuring IFN-alphabeta mRNA expression in different organs and cells
types, we show that in vivo, Ads elicit strong and rapid IFN-alphabeta production, almost exclusively in
splenic mDCs. Using knockout mice, various strains of Ads (wild type, mutant and UV-inactivated) and
MAP kinase inhibitors, we demonstrate that the Ad-induced IFN-alphabeta response does not require
Toll-like receptors (TLR), known cytosolic sensors of RNA (RIG-I/MDA-5) and DNA (DAI)
recognition and interferon regulatory factor (IRF)-3, but is dependent on viral endosomal escape,
signaling via the MAP kinase SAPK/JNK and IRF-7. Furthermore, we show that Ads induce
IFN-alphabeta and IL-6 in vivo by distinct pathways and confirm that IFN-alphabeta positively
regulates the IL-6 response. Finally, by measuring TNF-alpha responses to LPS in Ad-infected wild type
and IFN-alphabetaR(-/-) mice, we show that IFN-alphabeta is the key mediator of Ad-induced
hypersensitivity to LPS. These findings indicate that, like endosomal TLR signaling in pDCs,
TLR-independent virus recognition in splenic mDCs can also produce a robust early IFN-alphabeta
response, which is responsible for the bulk of IFN-alphabeta production induced by adenovirus in vivo.
The signaling requirements are different from known TLR-dependent or cytosolic IFN-alphabeta
induction mechanisms and suggest a novel cytosolic viral induction pathway. The hypersensitivity to
components of the microbial flora and invading pathogens may in part explain the toxic side effects of
adenoviral gene therapy and contribute to the pathogenesis of adenoviral disease.
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Abstract
The early systemic production of interferon (IFN)-ab is an essential component of the antiviral host defense mechanisms,
but is also thought to contribute to the toxic side effects accompanying gene therapy with adenoviral vectors. Here we
investigated the IFN-ab response to human adenoviruses (Ads) in mice. By comparing the responses of normal, myeloid
(m)DC- and plasmacytoid (p)DC-depleted mice and by measuring IFN-ab mRNA expression in different organs and cells
types, we show that in vivo, Ads elicit strong and rapid IFN-ab production, almost exclusively in splenic mDCs. Using
knockout mice, various strains of Ads (wild type, mutant and UV-inactivated) and MAP kinase inhibitors, we demonstrate
that the Ad-induced IFN-ab response does not require Toll-like receptors (TLR), known cytosolic sensors of RNA (RIG-I/MDA-
5) and DNA (DAI) recognition and interferon regulatory factor (IRF)-3, but is dependent on viral endosomal escape, signaling
via the MAP kinase SAPK/JNK and IRF-7. Furthermore, we show that Ads induce IFN-ab and IL-6 in vivo by distinct pathways
and confirm that IFN-ab positively regulates the IL-6 response. Finally, by measuring TNF-a responses to LPS in Ad-infected
wild type and IFN-abR2/2 mice, we show that IFN-ab is the key mediator of Ad-induced hypersensitivity to LPS. These
findings indicate that, like endosomal TLR signaling in pDCs, TLR-independent virus recognition in splenic mDCs can also
produce a robust early IFN-ab response, which is responsible for the bulk of IFN-ab production induced by adenovirus in
vivo. The signaling requirements are different from known TLR-dependent or cytosolic IFN-ab induction mechanisms and
suggest a novel cytosolic viral induction pathway. The hypersensitivity to components of the microbial flora and invading
pathogens may in part explain the toxic side effects of adenoviral gene therapy and contribute to the pathogenesis of
adenoviral disease.
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Introduction
Adenoviruses (Ads) cause mild disease in humans, but are
hazardous pathogens in immuno-compromised individuals [1].
Human Ads are dsDNA viruses grouped into six species. Species
A, C, D, E, and F and species B Ads use different infectious entry
pathways [2]. Human Ads enter mouse cells and express their
early genes; however, the virus genome is not replicated and no
viral progeny is made during the infection of mouse cells in vitro or
in vivo [3,4]. Furthermore, early viral gene expression can be
abolished by UV-inactivation and well-defined mutants with
defects of viral early genes or viral entry are available [3,5]. Thus,
the effects elicited by different components of the virus-host
interaction preceding viral replication can be accurately evaluated.
Ads transduce many different cell types and can be produced in
vitro in sufficiently high amounts for in vivo administration. While
these properties make them attractive for gene therapy applica-
tions, they can also trigger a severe systemic toxic reaction [6,7].
Upregulation of inflammatory mediators, including cytokines and
chemokines such as IL-1, IL-6, IL-8, IL-12, macrophage
inhibitory protein-1/2, tumor necrosis factor-a (TNF) and recently
also type I IFN has been observed in experimental and clinical
infections with wt as well as with recombinant Ads [6,7,8,9,10].
Type I IFNs represent one of the host’s most important antiviral
defense mechanisms. The type I IFN family comprises different
IFN-a subtypes, a single IFN-b and other less well characterized
proteins [11]. All IFN-a species and IFN-b interact with the same
IFN-ab cellular receptor, the activation of which mediates a wide
range of direct and indirect innate antiviral or antimicrobial effects
and modulates the antiviral adaptive immune response [12,13,14].
At present, two main mechanisms of type I IFN induction by
viruses resulting from the extracytoplasmic or cytoplasmic virus
recognition, respectively, are known [12,13,14,15]. The extra-
cytoplasmic induction is initiated by triggering the surface-
expressed transmembrane protein toll-like receptor (TLR) 4 with
certain non-nucleic viral constituents [16,17,18] or upon recogni-
tion of viral nucleic acids in the endosomes of specialized cells
(dendritic cells and macrophages) via different members of the
TLR family. These include TLR3, TLR7/TLR8 and TLR9,
sensing dsRNA, ssRNA and CpG DNA, respectively. For IFN-ab
PLoS Pathogens | www.plospathogens.org 1 November 2008 | Volume 4 | Issue 11 | e1000208
induction TLR3 and TLR4 signal through the adaptor molecule
TIR domain-containing adaptor protein inducing interferon b
(TRIF). This results in the activation of interferon regulatory factor
(IRF)-3. TLR7, 8 and 9 signal through the adaptor molecule
Myeloid differentiation factor 88 (MyD88). An important result of
the MyD88-mediated pathway is the activation of IRF-7 (but not
of IRF-3), which together with the transcription factors NF-kB and
AP-1 initiates the induction of both the IFN-a and IFN-b genes
[13,15]. This induction pathway is responsible for the strong, early
IFN-ab response to several replicating and inactivated viruses in
pDCs, which express preferentially TLR7 and TLR9 [19,20,21].
The ‘‘classical’’ cytosolic pathway is the major IFN-ab
producing mechanism in cells other than pDCs [22,23]. Signal
transduction leading to type I IFN gene induction is initiated by
the recognition of intracellular virus-associated molecular patterns.
dsRNA and 59-triphosphate RNA produced during viral replica-
tion are sensed by the RNA helicases RIG-I and MDA-5
[23,24,25,26,27,28]. This pathway has been extensively studied,
mainly in virus-infected fibroblasts. Triggering of the aforemen-
tioned RNA helicases leads to the activation of the transcription
factors NF-kB, IRF-3 and IRF-7 that are important for the
induction of IFN-ab and proinflammatory cytokines, including IL-
6. In the cytosolic pathway, type I IFN gene induction is a
sequential event and both IRF-3 and IRF-7 were shown to be
important in the early phase when mostly IFN-b is produced. The
late phase of the IFN-ab response is regulated by positive feedback
via the increased levels of IRF-7 elicited by IFN-b production
during the early phase [29,30,31]. In addition to fibroblasts, the
potential of mDCs and macrophages to produce significant
amounts of type I IFNs in response to viral replication has been
demonstrated in vitro [32,33]; however, in vivo the specific
contribution of these cells to systemic levels of IFN-ab is not well
documented.
Recently, detection of bacterial DNA in cells infected with L.
monocytogenes and recognition of transfected B-DNA has been
shown to trigger IFN-b production. This type of response strictly
requires IRF-3 [15,34,35,36,37,38]. Such a sensing system has
been suggested to represent a further mechanism of cytosolic DNA
virus recognition [14,15] and the Z-DNA binding protein 1 (Zbp1,
also referred as DNA-dependent activator of IFN regulatory
factors, DAI) was shown to be a candidate DNA sensor in this
pathway [39]. Notably however, in a follow-up study the same
group found a critical role for DAI in L-929 cells but not in mouse
embryonic fibroblasts (MEFs) [40]. Furthermore, recent experi-
ments with Zbp1/DAI knockout mice did not show the essential
role of Zbp1/DAI in the induction of innate and adaptive
responses to B-DNA in vivo and in macrophages, dendritic cells
and MEFs in vitro [41].
The induction of type I IFN in Ad-infected mice has been
recently studied [10,42] and associated with both the extracyto-
plasmic and intracytoplasmic pathways. It was claimed that a part
of the IFN-ab response is initiated by TLR9 and MyD88 signaling
in pDCs and another part by cytosolic DNA recognition in non-
pDCs. However, the identification of IFN-ab producing cell types
directly in infected mice was not carried out. In the present study
we investigated the IFN-ab responses of Ad-infected mice and
showed that the bulk of the in vivo induced IFN-ab is produced by
splenic mDCs. Furthermore, we found that TLRs, including
TLR9 play no major role. The Ad-elicited IFN-ab response
required viral endosomal escape, suggesting a cytosolic induction
pathway. Surprisingly however, the induction was independent of
IRF-3 and dependent on stress-activated protein kinase/c-Jun
NH2-terminal kinase (SAPK/JNK) activity, which is in contrast to
the known induction mechanism initiated through cytosolic DNA
recognition. Instead, the induction required IRF-7, and a positive
feedback regulation via the type I IFN receptor. Although this does
not exclude a role for cytosolic nucleic acid sensors, our data do
not support the involvement of MDA-5, RIG-I and Zbp1/DAI in
the induction of the IFN-ab response to Ad. Furthermore, our
results reveal distinct mechanisms in the induction of IFN-ab and
IL-6 by Ad. Finally, we show that Ad-induced IFN-ab is a key
mediator of hypersensitivity to bacterial lipopolysaccharides in
infected mice. Enhanced susceptibility to LPS and to other
microbial inducers of inflammation may contribute to toxic
reactions observed during adenoviral gene therapy and to the
clinical symptoms of adenoviral diseases.
Results
Induction of IFN-ab by adenovirus in mice is elicited by
viral entry and is inhibited by viral early gene expression
In order to characterize the induction of type I IFNs by Ad in
vivo, we first examined how two types of human Ad, Ad3 (species
B) and Ad R700 (species C) [2] known to use distinct infectious
entry routes, elicit an IFN-ab response in vivo. The results
summarized in Fig. 1A and supplementary Fig. S1A show that
all mice infected with either of the two viruses exhibited similar
IFN-ab responses. IFN-ab was first detectable in plasma at 4 h,
peaking at 8 h and declining to low levels 18 h after infection. We
then investigated, whether the expression of viral genes is required
and/or regulate the induction of IFN-ab by Ads. To this end, we
injected mice with an UV-inactivated Ad3 (Fig. S1B) or Ad R700,
incapable of viral gene expression, or with a recombinant Ad5
(species C) that contains a deletion of the E1 and E3 Ad early
regions and expresses GFP (Ad5-GFP) (Fig. S1C). As shown in
Fig. 1A, UV-inactivated Ads also induced a strong IFN-ab
response which, however, peaked at 6 h after injection, i.e. 2 h
earlier than the response to intact Ads. A similar early-peaking
IFN-ab response was obtained in mice injected with UV
inactivated Ad R700 (Fig. S2A) and with the recombinant Ad5-
GFP (Fig. S2B).
Author Summary
Adenoviruses (Ads) are important pathogens and promis-
ing vectors for gene therapy applications. In the course of
adenoviral infections innate immune responses are acti-
vated, which can be beneficial for the antiviral host
defense but also detrimental if activated in a deregulated
manner. Type I IFNs are crucial for the innate immune
control of various viral infections in the mammalian host.
So far, the early, systemic release of IFN-ab during viral
infections has been attributed to specialized immune cells,
the plasmacytoid dendritic cells. Here, in a mouse infection
model, we show that wild type Ads, as well as adenoviral
vectors, elicit rapid IFN-ab production almost exclusively in
another cell population, the splenic myeloid dendritic cells.
This IFN-ab storm depends on viral escape from endo-
somes to the cytosol and the requirements of the response
are suggestive of a novel viral induction pathway.
Furthermore, we show that virus induced IFN-ab is the
key mediator of Ad-induced hypersensitivity to the
cytokine-inducing and toxic activity of lipopolysaccharide,
a common constituent of Gram-negative bacteria. Since
these bacteria comprise several commensals and patho-
gens, enhanced susceptibility to lipopolysaccharide may
contribute to toxic reactions observed during adenoviral
gene therapy and to the clinical symptoms of adenoviral
diseases.
Innate Immune Response to Adenovirus
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Figure 1. IFN-ab and IL-6 responses to Ad infection in vivo and in vitro. (A) Kinetics of the IFN-ab response. Mice (4–5/group) were infected
intraperitoneally (i. p.) with 1.261010 intact Ad3 or 3.661010 of UV-inactivated Ad3 and IFN-ab in plasma collected at the indicated time points was
determined. 6 h and 8 h values were analyzed for statistical significance. One representative experiment of three is shown. (B, C) IFN-ab and IL-6
responses to graded doses of Ad3. Mice (4–6/group) were infected with 46109 (1), 1.261010 (2), 3.661010 (3) or 7.261010 (4) of intact or UV-
inactivated Ad3. Plasma for the determination of IFN-ab and IL-6 was collected 6 h after infection. One representative experiment of two is shown. (D)
Induction of IFN-ab in different cell types by Ad in vitro. BMMs, BMDCs and MEFs were infected with 600, 1800 and 5400 Ad2 particles/cell or left
uninfected. MEFs were also transfectected with Lipofectamine 2000-DNA complexes (DNA/Lp). IFN-ab was measured in cell-free supernatants 6 h
after infection. (E) Expression of viral E1A mRNA in infected cells. E1A and b-actin mRNAs were determined in cells 6 h after Ad2 infection by RT-PCR.
Innate Immune Response to Adenovirus
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Titration of the viral preparations in mice revealed that a positive
correlation between the viral dose and the height of the IFN-ab
response existed only when relatively small doses of intact Ads were
used. Higher doses of the Ads either did not elicit a further increase
of the IFN-ab response (Ad3, Fig. 1B) or led to a decrease of the
response (Ad R700, Fig. S2C). In contrast, injection of the
corresponding UV-inactivated Ads always led to a gradual increase
of the IFN-ab response and, at higher viral concentrations, even
exceeded the response obtained with intact viruses. Thus, the
expression of Ad genes is not required for the induction of IFN-ab in
mice. The data also indicate that the expression of early adenoviral
genes negatively regulates type I IFN production. Notably, the Ad
E1A gene has been shown previously to suppress Newcastle Disease
Virus and IRF-3 induced IFN-a4 promoter induction in transient
expression assays in fibroblasts [43].
Interestingly, however, viral gene expression did not inhibit the
production of IL-6 in either Ad3- or Ad R700-infected mice
(Fig. 1C and Fig. S2D). Further experiments revealed that, in
contrast to the UV-inactivated Ad, heat-inactivated Ad did not
elicit IFN-ab in mice (data not shown). Since heat inactivation
prevents the entry of Ad into cells ([44] and Fig. S2E), we conclude
that signal transduction leading to IFN-ab production is activated
during Ad entry.
Dendritic cells and macrophages, but not embryonic
fibroblasts or L-929 cells, produce type I IFNs after Ad
infection in vitro
Previous studies have shown that, depending on the inducing
virus, IFN-ab is produced ubiquitously or in a cell type specific
manner [13,14]. Here we stimulated different primary mouse cells,
including bone marrow derived mDCs (BMDC), bone marrow
derived macrophages (BMM), bone marrow derived pDCs and
mouse embryonic fibroblasts (MEFs), with Ad2 (species C) or Ad3
(species B). Six hours later, the IFN-ab content of culture
supernatants and the expression of the viral E1A gene in the cells
were determined. BMDC and BMM, but not MEFs, produced
IFN-ab (Fig. 1D), although all cell types were successfully infected as
shown by RT-PCR (Fig. 1E and not shown). Very similar results
were obtained when, instead of Ad2, Ad3 or the recombinant Ad5-
GFP were used for infection of the three cell types (not shown). In
addition, pDCs also produced IFN-ab in response to Ad infection in
vitro (Fig. S3A); however, only at high multiplicities of infection.
Finally, like MEFs, L-929 cells infected with Ad2 produced no IFN-
ab either (Fig. S3B). In agreement with previous studies [36,37],
MEFs and L-929 cells produced IFN-ab following transfection with
purified DNA (Fig. 1D and Fig. S10C). In addition to mouse DCs
and macrophages we also found that human monocyte-derived
DCs produced IFN-ab upon infection with the adenoviral vector
Ad5-GFP (Fig. S3C). The present data confirm that Ads can trigger
IFN-ab production in various immune cells in vitro [10,45,46].
However, it furthermore indicates that production does not proceed
ubiquitously in all types of infected cells.
Splenic myeloid dendritic cells are the major producers
of IFN-ab in Ad-infected mice
In order to identify the organ site of viral uptake and IFN-ab
production in vivo, we analyzed the expression of the early viral
gene E1A and of type I IFN mRNAs, respectively, in the spleen,
liver, lung and kidney of Ad3-infected mice. We found expression
of the early viral E1A gene in spleen and liver (Fig. S1B), but not in
lung and kidney (not shown), which agrees with earlier findings on
in vivo Ad tropism [47,48]. Expression of IFN-a and IFN-b mRNA
was below the level of detection in the organs of non-infected
controls. We also found that between 4 and 18 h after infection
IFN-a and IFN-b mRNAs were expressed at high levels in the
spleen (Fig. 1F), but surprisingly not in the liver, despite the
presence of Ad in both organs. As expected, IFN-ab was not
expressed in the virus-free lung or kidney of infected mice (Fig. 1F).
In order to identify the cell type(s) producing IFN-ab in vivo, we
isolated splenocytes from Ad infected animals 8 h after virus
treatment and separated them into CD11c+ (DC-containing) and
CD11c2 (non-DC) populations. Both CD11c+ and CD11c2
populations contained viral DNA (not shown). This finding is in
accordance with the report of Morelli et al describing that both
splenic DC and non-DC contain the virus in Ad-infected mice
[49]. However, quantitative RT-PCR determination of IFN-a and
IFN-b mRNA in both populations revealed the presence of IFN-
ab mRNAs predominantly in the DC-containing CD11c+ fraction
(Fig. 2A, B), but not in the macrophage containing CD11c2
fraction. In contrast to IFN-a and IFN-b, the mRNA levels of IL-
6, another cytokine known to be induced by Ad, were comparably
upregulated in both the CD11c+ and CD11c2 population
(Fig. 2C). Since the latter non-DC population comprises more
than 95% of all mouse splenocytes [50], we conclude that most of
the IL-6 made in the Ad-infected spleen is of non-DC origin.
According to published data, the CD11c+ cell population contains
different types of DCs, as well as other cells such as lymphocytes,
macrophages, granulocytes and NK cells [51,52,53]. We therefore
further separated the purified CD11c+ cells into mDCs
(CD11c+CD11b+Gr12), pDCs (CD11c+CD11b2GR1+B220+) and
a CD11c+CD11b-F4/80+ subpopulation (Fig. S4A–D) and measured
the expression of IFN-a, IFN-b and b-actin with real-time RT-PCR.
After normalization to b-actin expression, we found that on a per cell
basis mDCs expressed significantly more IFN-b than pDCs (Fig. 2D),
but both mDCs and pDCs expressed similar amounts of IFN-a
(Fig. 2E). In contrast, CD11c+, CD11b2 cells carrying the
macrophage marker F4/80+ did not express detectable amounts of
IFN-a or IFN-b. Since mDCs comprise approximately 60% of all
analyzed CD11c+ splenocytes and their numbers are approximately
10-times higher than those of pDCs (Fig. S5A, B and [50]), these
results suggested that the vast majority of IFN-ab in Ad-infected mice
was produced by splenic mDCs. To verify this assumption, we
analyzed the Ad-elicited cytokine responses in mice depleted of
CD11chigh MHC II+ myeloid DCs. To ablate these cells, we injected
diphtheria toxin into the CD11c-diphtheria toxin receptor
CD11cDTR/GFP transgenic mice [54] 24 h prior to infection with
Ad. In agreement with previous reports [55,56], DT pre-treatment of
DTR/GFP transgenic mice resulted in the ablation of CD11chigh
MHC II+ CD11b+ splenic mDCs, whereas the CD11cint Siglec H+
CD11b2 plasmacytoid DCs remained unaffected (Fig. S5A, B).
When DT pre-treated CD11cDTR/GFP transgenic mice were
challenged with Ad3 and examined for IFN-ab in plasma 4 and 8 h
after infection, only marginal IFN responses were found at both time-
points, in contrast to the strong responses of similarly infected
transgenic control mice that had not received DT (Fig. 3A). The same
Data in MEFs (lane 1, 2, 3) and BMDCs (lane 4, 5, 6) infected with 5400 (lane 1, 4) and 1800 (lane 2, 5) viral particles/cell and in mock infected cells (lane
3, 6) are shown. (F) Expression of IFN-b and IFN-a mRNA in organs of Ad-infected mice. (3 mice/group) were infected i.p. with 1.261010 Ad3 particles
and the relative levels of IFN-b and IFN-a mRNA in organs were analyzed at the indicated time points by RT-PCR. A representative organ sample per
each time point is shown. c+ indicates a spleen sample from a Ad3-infected mice used as a positive control. n.d.: not detectable.
doi:10.1371/journal.ppat.1000208.g001
Innate Immune Response to Adenovirus
PLoS Pathogens | www.plospathogens.org 4 November 2008 | Volume 4 | Issue 11 | e1000208
pretreatment with DT had no effect on the Ad elicited IFN-ab
response of wild-type mice (Fig. 3A).
Interestingly, the determination of IL-6 levels in plasma 8 h
after infection revealed that the ablation of mDCs in
CD11cDTR/GFP transgenic mice affected only moderately the
induction of IL-6 (Fig. 3B), confirming that non-DCs contribute
significantly to the Ad-elicited IL-6 response in vivo. The fact that
different cell types are responsible for IFN-ab and IL-6 response to
Ad may explain at least in part why viral gene expression did not
inhibit the production of IL-6 in Ad3- or Ad R700-infected mice
(see Fig. 1C and Fig. S2D). In order to functionally evaluate the
possible participation of pDCs to the systemic production of IFN-
ab to Ad we also checked this response in mice depleted of pDCs.
As shown in Fig. S6A and B, the injection of anti PDCA-1
antibody led to the substantial decrease of the number of splenic
pDCs. Nevertheless, the production of IFN-ab was not changed in
response to Ad infection (Fig. 3C). The data collectively show that
the vast majority of IFN-ab but not of IL-6 in Ad infected-mice is
produced by splenic mDCs.
Ad induction of type I IFNs is TLR independent
Recent studies have shown the involvement of different TLRs
including TLR 2, 3, 4, 7 and 9 in the innate recognition of
different viruses [16,17,18,57,58,59,60,61]. Signaling via TLR9
was shown to be responsible for the strong type I IFN response of
pDCs to Ad in vitro [10,45,46]. Here we investigated the possible
involvement of TLR9 in the induction of type I IFNs by measuring
IFN-ab in Ad infected wt and TLR92/2 mice. Fig. 4A shows that
TLR92/2 mice produced normal levels of IFN-ab. upon infection
with Ad3. Comparable results were obtained with the recombi-
nant Ad5-GFP (Fig. S7A). Moreover, Unc93B mice, deficient in
signalling by intracellular TLRs showed normal IFN-ab responses
to Ad5-GFP (Fig. S7A). We further checked the possible
involvement of the TLR system using mice deficient for TLR2,
TLR4 or for the TLR adaptor proteins TRIF and MyD88. Fig. 4A
shows that the Ad3 induced IFN-ab levels in all strains of mice
were as high as in the respective wt controls. Similarly, comparable
IFN-ab responses were also found in TLR-, MyD88- or TRIF-
deficient mice and in the corresponding wt animals after infection
Figure 2. IFN-ab and IL-6 mRNA levels in ex vivo purified splenocyte subsets from Ad infected mice. Spleens were removed from mice
8 hours after infection with 1.261010 Ad3 particles and from uninfected mice. Pooled splenocytes (3–5 mice/group) were MACS enriched for CD11c+
and CD11c2 cells and further purified with FACS-sorting after staining with antibodies to CD11c, Cd11b, Gr-1, B220 and F4/80. Gates used for the
purification of DC subsets are shown on Figure S4. The relative expression of IFN-b (A, D), IFN-a (B, E) and IL-6 (C) was measured in CD11c+ versus
CD11c2 cells (A,B,C) and in the mDC, pDC and F4/80+CD11b2 subsets of CD11c+ cells (D, E) using real-time RT-PCR. Triplicate measurements of a
representative experiment of three are shown. n.d.: not detectable.
doi:10.1371/journal.ppat.1000208.g002
Innate Immune Response to Adenovirus
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with UV-inactivated Ad3, AdR700 and Ad5-GFP (not shown).
Furthermore, comparable IFN-ab responses were found in
cultures of Ad-infected BMDCs from wt, MyD88- and TRIF-
deficient mice (Fig. 4B). The various TLR deficient mice showed
impaired responses to the corresponding ligands in control
experiments (Fig. S7B). Collectively, our data show that the
TLR system plays no major role in the systemic IFN-ab responses
to Ads in mice.
The induction of IFN-ab and IL-6 in response to Ad
infection is dependent on IFN-ab feedback signaling
The type of virus, the IFN-ab-producing target cell, and the
activation mechanism determines whether positive feedback
signaling is involved in the induction of the IFN-ab response or
not [13,20]. Here, we studied the possible involvement of IFN
feedback signaling in the IFN-ab and IL-6 response to Ad3 by
using wt and IFN-abR-deficient mice. The absence of the IFN-ab
receptor resulted in dramatically decreased levels of IFN-a and
IFN-b protein in the plasma as well as of IFN-a and IFN-b
mRNAs in the spleen (Fig. 5A, B) 4 and 8 h after Ad infection.
The difference between the protein or mRNA levels of IFN-a and
IFN-b in wt versus mutant animals was approximately 100 and 20-
fold, respectively. Furthermore, in contrast to wt mice, the
characteristic rise in IFN-ab levels between 4 and 8 h after
infection was absent in IFN-abR2/2 mice. Thus, in Ad-infected
mice, production of both IFN-a and IFN-b is strictly dependent on
positive IFN-ab feedback. The determination of IL-6 protein and
mRNA levels in the same plasma and splenic tissue samples
revealed that the induction of IL-6 is also positively regulated by
IFN-ab signaling (Fig. 5C), which is in agreement with a previous
study [10].
We also tested whether IFN-abR-dependent signaling is
involved in the IFN-ab response of Ad-infected BMDCs in vitro.
As with the in vivo results, we found that cells from IFN-abR2/2
mice infected with Ad3 produced significantly less type I IFN than
similarly infected cells from wt mice (Fig. S8). The loss of IFN-ab
signaling also resulted in a strong inhibition of the Ad induced IL-6
production in BMDCs (Fig. 5D) and BMMs (Fig. 5E). Further-
more, as shown using Ad-infected BMMs, it resulted also in a
strong reduction of inducibility of IL-6 mRNA expression (Fig. 5F).
Because transcriptional changes are often determined by epige-
netic factors [62] we checked the levels of hyperacetylated histone
H4 (acH4), a permissive factor for transcription at the IL-6
promoter in control and Ad-infected BMMs from wt and
IFNabR2/2 mice. Chromatin immunoprecipitation (ChIP) assays
showed a significant enrichment of acH4 at the IL-6 promoter in
infected wt, but not IFNabR2/2 BMMs (Fig. 5G). In a control
experiment, as expected, an enrichment of acH4 was observed at
the promoter of the constitutively active Topoisomerase 3b but not
of the l5 (not expressing, active only in early B-cells) gene in both
cells types. From these results we conclude that IFN-ab exerts a
positive regulatory effect on the Ad-induced IL-6 transcription and
that its loss is at least partly responsible for the strong reduction of
the IL-6 response in Ad-infected IFN-abR knockout mice.
Using real-time RT-PCR we then analyzed the spectrum of
IFN-ab genes in wt mice as well as the impact of IFNabR
deficiency on their induction. Included were IFN-a2, 4, 5, 6, 9, 11,
12, 13, 14 and IFN-b. All of them were induced in the spleen by
Figure 3. Splenic mDCs are the major IFN-ab-, but not the predominant IL-6-producing cells in adenovirus infected mice. Ad-induced
IFN-ab and IL-6 responses in mice depleted for mDCs and pDCs. Groups of wt and CD11c-DTR mice (4/group) were injected with DT i. p. or left
untreated. 24 h later the animals were injected with 1.261010 Ad3 particles and the plasma levels of IFN-ab (A) and IL-6 (B) were measured 4 and 8 h
after infection. Mice (4/group) were untreated or injected with 500 mg of anti-mPDCA-1 antibody i. p. and challenged with 1.261010 Ad3 particles.
Plasma IFN-ab levels were determined 8 h after Ad infection (C). The efficacy of splenic DC depletions is shown in Fig. S5 and S6.
doi:10.1371/journal.ppat.1000208.g003
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Ad3 in vivo and in BMDC in vitro. IFN-ab subtypes were not
detectable in the spleen of unstimulated mice or BMDCs (not
shown). Fig. 6 shows the patterns of IFN-ab genes induced in vivo
and in vitro in the presence or in the absence of IFN-ab feedback
signaling. In wt mice and cells IFN-a5 and IFN-b were the most
strongly expressed genes and IFN-a13 was the least activated IFN-
a subtype. IFN-a11 was not induced at all. IFNabR deficiency
resulted in an inhibition of IFN-ab gene expression, the strength of
which was subtype dependent. In some cases the inhibition was
weak (IFN-a2, 4, 5 and IFN-b), in others strong or complete (IFN-
a12, 13, and 14), showing that the expression of different subtypes
of IFN-ab are differentially affected by IFN-ab feedback signaling.
Collectively, these data show that the adenovirus triggered
production of IFN-ab and IL-6 in BMDCs in vitro and in mice
in vivo is strongly dependent on intact IFN-ab signaling.
The critical role of IRF-7 but not IRF-3 in Ad-induced type
I IFN production
The transcription factors IRF-3 and IRF-7 have distinct and
important roles in IFN-ab production induced by viruses or other
pathogens and their involvement can be characteristic for the
induction mechanisms involved [13]. Specifically, IRF-3 has been
shown to be critically involved in cytoplasmic DNA sensing and in
the Ad-induced IFN-ab production in BMMs in vitro [63]. We
show here that IRF-3 is critical for the induction of IFN-ab by
isolated adenoviral DNA, but not by infection with whole virions
in BMDCs (Fig. 7A). In order to analyze the individual
contribution of IRF-3 and IRF-7 to the Ad-induced IFN-ab
response in vivo, we infected mice deficient for these transcription
factors with Ad3. We also compared these responses to those
triggered by poly I:C, a known activator of the cytosolic IFN-ab
producing pathway in vivo. As shown in Fig. 7B, the lack of IRF-3
did not significantly influence the plasma levels of IFNab 4 or 8 h
after infection in response to Ad. In contrast, Ad-infected IRF-7-
deficient mice did not exhibit detectable amounts of IFN-ab in the
plasma. Very similar data were obtained with Ad5GFP (Fig. S9).
Thus, IRF-7, but not IRF-3, is essential for the induction of the
IFN-ab response during Ad infection. Compared to wt mice, poly
I:C injected IRF-7 deficient mice produced significantly less, but
still well detectable amounts of IFN-ab.
The nucleic acid sensors MDA-5, RIG-I and DAI/Zbp1 are
not critical for Ad-induced type I IFN production
Next, we investigated whether the cytoplasmic RNA sensors
MDA-5 or RIG-I, or the putative DNA sensor DAI/Zbp1 may
play a major role in the induction of the IFN-ab response to Ad.
The possible involvement of MDA-5 was tested using BMDCs and
BMMs from MDA-5 deficient mice. Normal IFN-ab responses to
Ad were obtained in MDA-5-deficient BMDCs cells (Fig. 8A) and
also in BMMs (not shown), whereas the responses to the known
MDA-5 ligand Poly I:C were abrogated (Fig. 8A). The possible
involvement of RIG-I was checked using a dominant negative
form of RIG-I (RIG-IC) [64]. BMDCs from IRF-32/2 mice were
transfected with a GFP-expressing plasmid (transfection control)
with or without RIG-IC and subsequently stimulated with Ad or
control leader RNA. We used IRF-32/2 cells to avoid any
induction of IFN-ab by the plasmid itself, which is, contrary to
that by Ad, strictly IRF-3 dependent. The induction of IFN-b
mRNA was analyzed in sorted GFP-positive cells. As shown in
Fig. 8B, left, the transfection of RIG-IC prevented induction of
IFN-b mRNA by the leader RNA, but not by Ad. The role of
Zbp1/DAI was analyzed using siRNA-mediated knockdown of
DAI/Zbp1 in BMDCs. For this purpose, cells from IRF-32/2
mice were co-transfected with DAI/Zbp1 targeting siRNAs and a
GFP expressing plasmid and subsequently stimulated with Ad. As
shown in Fig. 8B, right, the transfection of BMDCs resulted in
strongly reduced DAI/Zbp1 expression but not in a reduced IFN-
b mRNA induction by Ad in GFP-positive cells. Control
experiments with L-929 cells showed that transfection of the
gene-specific siRNA downregulated the expression of DAI/Zbp1
on both the mRNA and protein levels and efficiently inhibited the
IFN-b response to B-DNA (Fig. S10A–C). Collectively, our results
indicate that known nucleic acid sensors such as MDA-5, RIG-I
and Zbp1/DAI are not involved in the Ad-induced type I IFN
production.
SAPK/JNK signaling is activated upon Ad infection and is
necessary for virus elicited IFN-ab and IL-6 production
MAPKs have been previously shown to be activated by Ad in
vitro, in different non-immune cell types and to be important for
the induction of chemokines in response to Ad [65,66,67,68]. Here
we investigated whether members of the MAPK family play a role
in the Ad-induced IFN-ab and IL-6 response. We infected
BMDCs with Ad3 in the presence or absence of MAPK inhibitors
Figure 4. Adenovirus induction of IFN-ab is TLR independent.
(A) IFN-ab responses to Ad in mice with impaired TLR signaling. IFN-ab
was measured in plasma of mice (4–6/group) of the indicated
genotypes 8 h after i. p. infection with 1.261010 Ad3 particles. One
representative experiment of three is shown. (B) IFN-ab response to Ad
in BMDC with impaired TLR signaling. BMDC generated from wt,
Myd882/2 and TRIF2/2 mice were infected in vitro with 600, 1800 and
5400 Ad3 particles/cell or were mock-infected. IFN-ab was measured in
cell-free supernatants 16 h after infection. One representative experi-
ment of three is shown. n.d.: not detectable.
doi:10.1371/journal.ppat.1000208.g004
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Figure 5. Role of IFN-ab feedback in Ad-induced IFN-ab and IL-6 responses. (A–C) Role of IFN-ab feedback signaling in vivo. Wt (empty bars)
and IFN-abR2/2 (black bars) mice (4–6/group) were infected with 6.261010 Ad3 particles. Four and 8 h after infection, the protein and mRNA levels of
IFN-b (A) IFN-a (B) and IL-6 (C) were determined in plasma and spleen with bioassay and real-time RT-PCR, respectively. (D-G) Role of IFN-ab feedback
signaling in Ad induced IL-6 production. BMDCs (D) from wt and IFNabR2/2 mice were mock-infected or infected with 600, 1800 and 5400 Ad3
particles/cell. Wt and IFNabR2/2 BMMs were mock-infected or infected with 5400 Ad5 GFP particles/cell (E–G). IL6 was measured in cell-free
supernatants 16 h (D) or 8 h (E) after infection. IL-6 mRNA was quantified 8 h after infection (F). Acetylation of histone H4 was measured at the IL-6,
topoisomerase 3b and l5 promoters 8 h after infection. Mock immunoprecipitated samples showed no significant values (less than 0.1%) for all
samples, not shown. (G). One representative experiment of three (D) or two (E) is shown.
doi:10.1371/journal.ppat.1000208.g005
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Figure 6. Ad-induced pattern of IFN-ab subtypes in vivo and in vitro in the presence and absence of IFN-ab feedback. The expression of
different IFN-ab subtypes was analyzed by real-time RT PCR in total RNA prepared from the spleen or from in vitro generated BMDCs of wt or IFN-
abR2/2 mice 8 h after infection with 6.261010 Ad3 particles/mouse (in vivo) or with 900 particles/cell (in vitro). One representative experiment of two
is shown. (1) IFN-a2, (2) IFN-a4, (3) IFN-a5, (4) IFN-a6, (5) IFN-a9, (6) IFN-a11, (7) IFN-a12, (8) IFN-a13, (9) IFN-a14, (10) IFN-b. n.d.: not detectable.
doi:10.1371/journal.ppat.1000208.g006
Figure 7. Adenovirus induction of IFN-ab requires IRF-7 but is independent on IRF-3. Wt and IRF-32/2 BMDCs were infected with 0, 600,
1800 and 5400 Ad5GFP particles/cell or were transfected with Ad5GFP DNA (2 mg/ml), Ad2Ts1 (26109 whole virus particles/ml) and empty Ad5 GFP
(26109 whole virus particles/ml) with Lipofectamine 2000. IFN-ab was measured in cell-free supernatants 16 h after infection (A). One representative
experiments of three is shown. Wt, IRF-32/2 and IRF-72/2 mice (4–6/group) were infected with 6.261010 Ad3 particles, i.p. (B) or injected with 5 mg of
poly I:C i. p. (C) Plasma IFN-ab was measured 4 and 8 h (B) or 3 h (C) after stimulation. One representative experiment of two is shown. n.d.: not
detectable.
doi:10.1371/journal.ppat.1000208.g007
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and determined the levels of IFN-ab and IL-6 produced. Fig. 9A
and Fig. S11 show that the pharmacological blockade of the
SAPK/JNK MAPK almost completely inhibited the Ad3-induced
production of both IFN-ab and IL-6. In contrast, the inhibition of
the p38 MAPK pathway partially inhibited the production of IL-6,
but had no effect on the production of IFN-ab. Finally, the
blockade of ERK1/2 had no effect on the production of either IL-
6 or IFN-ab. Very similar data on the effects of MAPK inhibitors
were obtained using Ad2 and mutant Ad5-GFP to stimulate
BMDC (data not shown).
Next, we analyzed the levels of activated SAPK/JNK MAPK
proteins in BMDCs and found their robust phosphorylation 2 h
after either Ad3 or Ad5-GFP infection (Fig. 9B). We also tested the
importance of SAPK/JNK signaling on Ad-induced IFN-ab
production in vivo. Fig. 9C shows that the blockade of the SAPK/
JNK signaling pathway in mice completely inhibited the
production of IFN-ab at 4 and partially at 8 h after Ad infection.
Taken together, these data strongly indicate that the Ad-activated
SAPK/JNK MAPK pathway plays an important role in the virus-
induced production of type I IFNs and IL-6.
Endosomal escape triggers the Ad-induced production
of IFN-ab and IL-6, but prevents TLR9-dependent innate
recognition
During the course of our adenovirus preparations, we regularly
found ‘‘empty capsids’’ which we separated and purified in
addition to the mature virions. We tested the IFN-ab stimulating
activity of these preparations in vivo and observed that they were
not active (Fig. S12A). Since empty capsids lack viral DNA and
exhibit an altered protein composition [69], the absence of an
inducing viral constituent(s) from these capsids could explain their
inability to provoke an IFN-ab response. Another possible
explanation could be that endosomal escape is required for IFN-
ab induction, since empty capsids cannot escape from the
endosome [69]. To test the latter possibility, we infected mice
with 3.661010 viral particles of wt Ad2 and Ad2Ts1, a viral
mutant deficient in endosomal escape [5]. As shown in Fig. 10A, in
contrast to the wt virus, Ad2Ts1 did not induce detectable levels of
type I IFN at 4 and 8 h after infection. Furthermore, the IL-6
response was also severely reduced in these animals (Fig. S12B). In
a control experiment, mice infected with Ad2Ts1 grown at
permissive temperature (32uC) and thus capable of endosomal
escape, exhibited normal IFN-ab responses (Fig. 10B). The
inability of Ad2Ts1 to escape from endosomes of mDCs was
confirmed by electron microscopy (Fig. 10E–H) and in vivo by the
lack of Ad early E1A gene expression in the spleen of mice infected
with Ad2Ts1 (Fig. 10I). Thus, escape from the endosome is critical
for the induction of IFN-ab and IL-6 by adenoviruses.
It should be noted that a further increase in the Ad2Ts1 dose
(2.1661011 particles) resulted in detectable, albeit very low levels
of plasma IFN-ab that were released with different kinetics
(Fig. 10C). In this case, IFN-ab was detectable as early as 2 h after
infection and, in contrast to the results we obtained with wt viruses
(Figures 1A, 10A and S1A), the levels of IFN-ab did not increase
significantly at the later time-points. This already suggests a
mechanism for type I IFN induction by Ad2Ts1 that is
fundamentally different from the IFN-ab induction seen with wt
Ad2. Since Ads are DNA viruses, they can possibly be detected by
TLR9. In fact, the innate immune recognition of Ad in pDCs is
TLR9 dependent. We therefore repeated the experiment with a
high dose of Ad2Ts1 using TLR92/2 mice. As shown in Fig. 10C,
TLR92/2 mice did not produce IFN-ab in response to the mutant
Ad2Ts1, quite in contrast to the results obtained with the wt virus
(see Fig. 4A) Likewise, there was no detectable IFN-ab release in
Ad2Ts1-infected mice deficient in MyD88, an essential compo-
nent of TLR9 signaling (not shown). Furthermore, the corre-
sponding amount of empty particles (DNA-free) of Ad2Ts1 elicited
no IFN-ab response in wt mice (Fig. 10C). These data illustrate the
critical role of TLR9 in the induction of IFN-ab by means of high
doses of Ad2Ts1. To exclude the possibility that contaminating
DNA on the surface of the virions was responsible for the TLR9-
dependent IFN-ab induction, we treated the mutant virions with
bensonase, which destroys all kinds of free nucleic acids.
Bensonase-treated Ad2Ts1 still induced an IFN-ab response in
Figure 8. IFN-ab production after adenovirus induction is
independent of known cytosolic nucleic acid sensors. Wt and
MDA-52/2 BMDCs were infected with 0, 600, 1800 and 5400 Ad5GFP
particles/cell, or stimulated with synthetic poly I:C (10 mg/ml) or leader
RNA complexed with Lipofectamine 2000 (0.1 mg/ml). IFN-ab was
measured in cell-free supernatants 16 h after infection (A). IRF-32/2
BMDCs were transfected with pmaxGFP (1 mg/36105 cells) alone and
together with RIG-IC (1 mg/36105 cells) or with DAI/Zbp1 targeting
siRNAs (0.3 mM/36105 cells). Twentyfour hours later cells were infected
with 5400 Ad5GFP particles/cell. Alternatively, RIG-IC transfected cells
were stimulated with synthetic leader RNA (0.1 mg/ml) complexed with
Lipofectamine 2000. Expression of IFN-b mRNA was measured in sorted
GFP+ cells 12 h after stimulation. Knockdown of DAI/Zbp1 expression
was measured in siRNA transfected cells (B).
doi:10.1371/journal.ppat.1000208.g008
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mice (not shown) supporting the view that endogenous viral and
not contaminating DNA is responsible for IFN-ab induction by
the Ad trapped in the endosomes.
We also tested the role of endosomal escape of Ad in the in vitro
induction in BMDCs of IFN-ab and IL-6. Fig. 10D shows a dose
dependent production of IFN-ab by Ad2Ts1 grown at permissive
Figure 9. Adenovirus induction of IFN-ab is dependent on SAPK/JNK signaling. (A) Effect of MAPK inhibitors on the IFN-ab response of
BMDC to Ad. BMDC from mice were pretreated for 15 min with the inhibitor SP600125 (for SAPK//JNK), UO126 (for ERK1/2), SB 203580 (for p38) or
with the diluent only as described in Materials and Methods, and then infected with 600, 1800 and 5400 Ad3 particles/cell or mock-infected. IFN-ab
was measured in cell-free supernatants 6 h after infection. n. d.: not detectable. (B) Inhibition of SAPK/JNK activation by SP600125 in Ad-infected
BMDC. BMDCs were pretreated with SP600125) or with diluent for 15 min and then infected with 5400 Ad3 or Ad5 particles/cell, or were mock-
infected. Total cell lysates obtained at the indicated times after Ad were analyzed by immunoblotting using antibodies to the total or phosphorylated
p46 and p54 SAPK/JNK isoforms. (C) The effect of SP600125) treatment on the IFN-ab production in Ad-infected mice. B6 Mice (4/group) were
pretreated with the SP600125 inhibitor (20 mg/kg) i.p. or with diluent for 45 min and then infected with 3.661010 Ad5-GFP particles. Plasma IFN-ab
was measured 4 and 8 h after infection. One representative experiment of three is shown.
doi:10.1371/journal.ppat.1000208.g009
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Figure 10. Requirement for viral endosomal escape in the induction of IFN-ab by adenovirus in vivo and in vitro. Comparison of the
cytokine responses of mice infected with wild-type Ad2 or mutant Ad2Ts1 virus grown at the non-permissive (38.5uC) or permissive (32uC)
temperature. B6 Mice (4/group) were infected with 3.661010 virus particles i. p. and plasma IFN-ab was measured 4 and 8 h (A) or 2 and 8 h (B) after
infection. n.d.: not detectable. IFN-ab responses to high doses of Ad2Ts1 virus in vivo. Wt or TLR9 deficient (4 animals/group) mice were infected with
2.1661011 Ad2Ts1-38.5uC particles, i.p. or with the same number of Ad2Ts1-38.5uC empty particles as indicated. IFN-ab levels were measured in
plasma at the indicated time-points after infection (C). Comparison of IFN-ab responses of BMDCs infected with Ad2Ts1 grown at permissive or non-
permissive temperature. BMDCs were infected with 1800, 5400, and 16 200 particles of Ad2Ts1-32uC/cell or with 32 400 particles of Ad2Ts1-38.5uC/
cell or were mock-infected. IFN-ab was measured in cell-free supernatants 16 h after infection (D). One representative experiment of two is shown.
(E–H) Incoming Ad2 but not Ad2-ts1 particles localize to the cytosol of mDCs. Myeloid dendritic cells were infected with Ad2 or Ad2-ts1 (38.5uC),
warmed to 37uC for 4 h, fixed and processed for transmission EM analysis as described in Materials and Methods. (E) and (F) show images of Ad2 and
Ad2-ts1 infected cells, respectively, and panel (G) depicts a fraction of a non-infected cell. Statistical analyses of Ad2 and Ad-ts1 particles at the plasma
membrane outside of the cell, in endosomes and the cytosol are shown in (H). (I) Absence of viral E1A expression in the spleen of Ad2Ts1-infected
mice. Mice (2/group) were infected with 3.661010 Ad2 or Ad2Ts1 (Ts1) particles, i. p. The expression of E1A mRNA in the spleen 6 h after infection was
analyzed by RT-PCR in samples from the individual Ts1-infected (lane 1, 2) and Ad2-infected (lane 3, 4) mice.
doi:10.1371/journal.ppat.1000208.g010
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temperature and Figures S12C and D the production of IFN-ab
and IL-6 by wt Ad2, but no production of either of the cytokines
by Ad2Ts1 grown at the restrictive temperature. Interestingly,
liposomal transfection of whole Ad2 Ts1 virions (but not of empty
virus particles) in BMDCs resulted in the significant production of
IFN-ab that however, was critically dependent on IRF-3 (Fig. 7A).
Similarly, Ad2 Ts1 did not induce IFN-ab production in human
monocyte derived DCs (Fig. S12E). The requirement of low pH
for Ad3 infection was also tested using bafilomycin A1, a drug
known to inhibit the acidification of endosomes. Experiments
shown in Fig. S13A, B revealed that cells treated with this drug
produced significantly reduced levels of IFN-ab and IL-6
respectively, in response to Ad3. This is consistent with the notion
that Ad3 and Ad7 infection of cultured cells requires low
endosomal pH [70,71]. Similar results were obtained using
treatment with ammonium chloride, another acidification inhib-
itor known to block Ad escape from endosomes (not shown).
Collectively, the data in vitro and in vivo provide evidence that the
late phase of the Ad infectious entry, in which the virus escapes
from the endosome, triggers an innate response characterized by
the production of type I IFNs and IL-6.
Ad elicited IFN-ab production leads to LPS
hypersensitivity
Induction of type I IFNs was shown to be critical for some
innate immune responses to Ads [10].We therefore investigated
whether a characteristic consequence of infection with Ad, the
induction of LPS hypersensitivity [72], might be mediated by type
I IFNs. For this purpose, we infected wt and IFNabR2/2 mice
with Ads, challenged them 16 h later with LPS and measured the
TNF-a response. Non-infected LPS-treated mice served as a
control. Unlike the infected wt mice, the Ad3-infected IFNabR2/2
mice did not exhibit enhanced responses to LPS (Fig. 11A).
Interestingly, LPS hypersensitivity developed also in mice injected
with very small amounts of Ad. Such amounts were capable of the
elicitation of IFN-b mRNA in the spleen of infected animals, but
incapable of inducing detectable circulating IFN-ab (Fig. S14A and
B). Similar results were obtained in Ad5-GFP-infected mice (not
shown). Furthermore, in IRF-72/2 mice that exhibit a severe
impairment of the IFN-ab response to Ad a severe impairment of
LPS sensitization by Ad5-GFP was also observed. (Fig. 11B). In
contrast, sensitization to LPS developed normally in Ad5-GFP-
infected TLR92/2 mice (Fig. 11B), which is in agreement with our
finding that TLR9 is not critical for the induction of IFN-ab by Ad.
Furthermore, only Ad5-GFP-infected wt, but not IFNabR2/2 mice
exhibited enhanced susceptibility to LPS shock (Fig. 11C). Notably,
also Ad vector-infected or IFN-a treated human monocyte-derived
mDCs exhibited enhanced sensitivity to LPS and overproduced
TNF-a upon LPS challenge (Fig. S14C). On the whole, our results
indicate that IFN-ab is an essential mediator of the LPS
hypersensitivity induced by adenovirus infection.
An increased expression of the LPS receptor complex on target
cells, may contribute to the enhanced reactivity to LPS [73,74].
We therefore investigated whether macrophages of Ad infected
mice overexpress the receptor components mCD14 and TLR4/
MD-2. We found that splenic macrophages from Ad infected mice
overexpress mCD14 in an IFN-ab dependent manner (Fig. 11D)
but the expression of TLR4/MD-2 was only minimally affected
(Fig. S14D). Furthermore, we found increased acetylation levels of
histone H4 at the TNF-a promoter in Ad-infected wt, but not in
IFNabR-deficient macrophages (Fig. 11E). This suggests that Ad-
induced IFN-ab increases LPS-induced TNF-a production, at
least in part by epigenetic changes at the TNF-a promoter.
Discussion
In the present study we investigated the IFN-ab response of
mice infected with human Ads. We showed that the response is
characterized by high levels of IFN-a and IFN-b, which are
produced simultaneously and almost exclusively by splenic mDCs.
Furthermore, the response is entirely independent of viral
replication, TLR-, MyD88-, TRIF- and IRF-3-signaling, but
dependent on viral escape from the endosomes, activation of the
SAPK/JNK pathway and IRF-7, and subsequent IFN-ab
feedback signaling. These data suggest an IFN-ab induction
pathway that is different from the extracytoplasmic and cytoplas-
mic pathways so far described. Finally, we show that IFN-ab is a
key mediator of the hypersensitivity to bacterial lipopolysaccha-
ride, which develops, in Ad-infected mice.
Adenoviruses, DCs and other IFN-ab producing cell types
As shown previously and in this study, a wide spectrum of cells
including pDCs, mDCs and macrophages [10,45,46,63] produce
IFN-ab in response to Ad in vitro. The present finding that in vivo,
in Ad-infected mice, splenic mDCs are the major source of IFN-ab
is surprising, since in mice infected with different viruses (MCMV,
HSV, VSV, MHV, influenza, vaccinia and Sendai viruses)
[27,57,58,59,75,76,77,78] pDCs activated by the TLRs constitute
the major contributors to the systemic levels of type I IFNs. In the
present study the expression levels of IFN-ab mRNAs in organs
and cells from Ad-infected mice suggested a dominant role for
splenic mDCs in the IFN-ab response. Furthermore, the IFN
response to Ad was practically absent in mice depleted of
CD11chigh MHC II+ myeloid DCs. Also, there was a striking
similarity between the IFN-ab subtypes induced by Ads in the
spleen of infected mice and those induced in mDC cultures in vitro.
It should be emphasized that in mice infected with VSV, in which
splenic pDCs are the main IFN producers, the spectrum of in vivo
induced IFN-a subtypes was markedly different [76]. Finally, the
finding that the response of Ad-infected mice was completely
independent of TLR signaling and strongly dependent on IFN-ab
feedback provide further arguments against a major role for pDCs.
In a number of viral infection models, IFN-a and -b production by
pDCs was mediated by TLR7/9 [13,19,23] and was at least
partially independent of a positive IFN-ab feedback [76,77,79,80].
In variance to our data, pDCs and various types of non-pDCs
[10,42] were suggested to be responsible for the type I IFN
responses to adenoviral vectors in mice. In [10] the loss of TLR9
signaling resulted in a reduction of the IFN-a response in mice
infected with the recombinant species C Ad-lacZ [10]. This
finding suggested a significant contribution of TLR9, and
therefore of pDCs, to the Ad-induced IFN-ab response in vivo.
The ratio of pDCs to mDCs (approximately 1:1) in the spleen of
animals used in the above study was quite different from that we
and others [50] have found (approximately 1:10). This may
explain the conflicting results on the role of TLR9 in vivo, between
this previous study and ours. In another study [42] the induction of
IFN-ab was studied in mice with an artificially enlarged pool of
DCs (due to prior pretreatment with sFLT-3L), 24 h after
recombinant Ad administration. In our study naı¨ve mice were
used and 24 h after Ad infection the levels of IFN-ab were already
below the detection limit. Of note also, the bone marrow stromal
antigen 2 (BST2) (that is recognized by the PDCA-1 antibody used
for isolation of pDCs in [42]), was shown to be up-regulated on
numerous cell types following stimulation that triggers an IFN
response [81]. Thus, the use of the PDCA-1 antibody for the
isolation of pDCs seems to be more reliable in the case of
uninfected mice [81].
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Recently, an absolute IRF-3 dependency of the in vitro IFN-ab
response of bone marrow derived macrophages to Ad has been
reported [63]. In our study IRF-3 deficiency had no significant
effect on the levels of IFN-ab induced in Ad-infected mice. In
addition, in Ad-infected macrophages, the relatively low level of
IFN-a4 mRNA and its negative regulation by the autocrine
Figure 11. Adenovirus triggered IFN-ab production is the mediator of LPS hypersensitivity. Wild-type and IFN-abR2/2 mice (4–6 mice/
group) were infected i. p. with 161010 Ad3 particles or left uninfected. 16 h later the animals received 1 mg LPS i. p. or diluent only. TNF-a was
determined in plasma 2 h after challenge (A). One representative experiment of three is shown. n.d.: not detectable. IRF-72/2 and TLR92/2 mice were
infected i. p. with 26109 Ad5 GFP particles and injected 16 h later with 1 mg LPS i. p. TNF-a was determined in plasma 2 h later (B). IFN-ab signaling is
required for Ad infection augmented LPS lethality. Wt and IFNabR2/2 mice were infected with 161010 Ad5 GFP particles i. p. or left uninfected. 16 h
later mice were injected with 3.5 mg LPS/gr. bw. The number of dead/total animals are shown at the indicated time after LPS challenge (C). Ad
infection increases mCD14 expression on splenic macrophages in an IFN-ab signaling dependent manner. Wt and IFN-abR2/2 mice were infected
with 161010 Ad5 GFP particles i. p. or left uninfected. Expression of mCD14 was measured on the surface of F4/80+ splenic macrophages by FACS
16 h after infection (D). Ad infection increases acetylation of histone H4 in wt macrophages at the TNF promoter. Wt and IFNabR2/2 BMMs were
mock-infected or infected with 5400 Ad5 GFP particles/cell and levels of acetylation of histone H4 were measured at the TNF-a promoter with ChIP
assays (E). Representative experiments of two are shown.
doi:10.1371/journal.ppat.1000208.g011
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feedback was different from our in vivo findings (strong induction
and positive regulation by feedback). This is in agreement with the
concept that in vivo macrophages make no significant contribution
to the IFN-ab response to Ad. A likely explanation is that the
induction of IFN-ab in macrophages requires the high numbers of
virions used in vitro, and that such multiplicities were never reached
in vivo. Interestingly however, in contrast to IFN-ab induction, the
induction of IL-6 proceeded in the spleen of infected mice in both
DC and non-DC populations. In accordance, the depletion of
IFN-ab-producing mDCs in mice prior to infection lowered, but
did not entirely prevent the IL-6 response. It is possible that the
pathways leading to the induction of IFN-ab and IL-6 by Ad are
different, at least in different cell types. Alternatively, in vivo, part of
the IL-6 formed is induced indirectly via secondary mechanisms.
In this context it is interesting that blockade of the p38 MAPK in
mDCs in vitro had no effect on Ad-induced IFN-ab production, but
partially inhibited the production of IL-6. Our data showing that
IFNabR2/2 mice exhibit strongly impaired IL-6 responses to Ad
is in agreement with a previous report [10] and shows that IFN-ab
is a positive regulator of IL-6 production. Moreover, our data
indicate that this effect could be explained at least in part by the
positive regulatory effect of IFN-ab on Ad-induced IL-6
transcription and is achieved by the alteration of the chromatin
structure at the IL-6 promoter.
Requirements for IFN-a/b induction by adenoviruses and
its relation to known induction pathways
The experiments carried out in this study in MyD88-, TRIF-,
Unc93B and various TLR-deficient mice excluded a participation
of TLRs in the IFN-ab responses to Ads, including the
recombinant Ad5-GFP. The only exception was the TLR9- and
MyD88-dependent IFN-ab response elicited by Ad2Ts1, a mutant
virus deficient in endosomal escape [5]. However, compared to all
other Ads used in this study, Ad2Ts1 induced very low levels of
IFN-ab, with faster kinetics and only when used in very high
amounts. This is consistent with the finding that the mechanisms
of type I IFN induction by Ad2Ts1 and the other adenoviruses are
not the same. We suggest that the fast escape of Ads from the
endosome circumvents activation of endosomal TLRs. The
requirement for a longer endosomal retention time in TLR9-
dependent IFN-ab production has been recently demonstrated
[82]. On the whole, our experiments indicate that Ad endosomal
escape is required for the induction of IFN-ab in vivo and suggest a
cytosolic pathway. The same requirement was ascertained in the
present study for the IL-6 response.
Sensors of nucleic acids are powerful initiators of the TLR-
independent cytosolic IFN-ab induction [12,14,15]. We excluded
in this study a major involvement of the cytoplasmic RNA sensors
RIG-I and MDA-5 in the induction of IFN-ab by Ads. Likewise,
our study does not support a major participation of the cytosolic
DNA sensor DAI/Zbp1 in this induction either. However, our
study did not formally exclude the existence of all potentially
redundant recognition pathways. So far reported, the pathway(s)
of IFN-ab induction activated by cytosolic DNA is (are) strictly
dependent on IRF-3 and minimally on IRF-7 [34,35,36,37,39].
IRF-3 was also reported to be essential for the adenoviral DNA-
dependent induction of IFN-ab in BMMs in vitro [63]. In
agreement, in this study we show that transfection of BMDCs
with naked adenoviral DNA or with whole virions of the
endosomal escape deficient Ad2Ts1 results in a strictly IRF-3
dependent IFN-ab response. Evidently however, the IFN-ab
response of Ad-infected BMDCs and mice is independent of IRF-
3. These findings do not exclude a requirement for dsDNA
recognition in the induction of IFN-ab, but suggest a different
induction mechanism and show the importance of cellular
compartmentalization during normal Ad entry. A possible
important factor involved in cytosolic Ad sensing might be the
adenoviral cysteine protease L3/23, whose activation requires the
presence of Ad DNA [83]. This assumption is supported by our
finding that a small fraction of the protease-lacking Ad2Ts1 still
reaches the cytosol (Fig. 10F, H), but is devoid of any IFN-ab-
inducing activity. This enzyme, apart from its involvement in
maturation of viral proteins and endosomal escape, is essential for
the stepwise disassembly of Ads in the cytosol and the release of
viral DNA at the nuclear pore [5].
The absolute requirement of IRF-7 for type I IFN induction in
Ad-infected mice shows that this transcription factor participates
not only in the positive IFN-ab feedback, but also in the initial
IFN-ab production and indeed plays a master role in the
regulation of type I interferon response [29].
A further finding of the present study is the essential role for the
MAPK SAPK/JNK in the IFN-ab induction by Ads in vitro and in
vivo, although the DNA-mediated cytosolic induction of IFN-ab
has been reported to be independent of MAPKs activation
[14,15,36]. A cytosolic dsDNA-signaling pathway, mediated by
the RNA helicase RIG-I and MAVS, and leading to the induction
of IFN-b has been recently demonstrated in human hepatoma
cells [84]. This induction pathway is absent in murine systems
[22,37,84,85] and is therefore unlikely to participate in the IFN-ab
response of Ad-infected mice.
On the whole, our findings do not support the participation of
any known nucleic acid-mediated mechanisms in the elicitation of
IFN-ab responses to human Ads. In this context it is interesting
that, as shown here, mouse embryonal fibroblasts do not produce
IFN-ab upon Ad infection, although they posses efficient cytosolic
induction pathways for dsRNA or dsDNA [13,36,37], the latter
shown also in this study. Rather, our data support the possibility
that the IFN-ab response to Ads occurs via a novel, not yet
characterized cytosolic DNA or protein recognition pathway.
Further studies are required to identify the viral components and
the host receptors involved. We also emphasize that the known
extra- and intra-cytosolic induction pathways may contribute to
the IFN-ab response in a host in which Ads replicate and free viral
dsRNA and dsDNA are generated.
As mentioned above, the production of IFN-ab in Ad-infected
mice is strongly dependent on IFN-ab feedback signaling.
Inhibition of positive IFN-ab feedback is a likely explanation for
the negative regulation of the IFN-ab response, observed, in mice
infected with intact Ads (expressing early genes) in this study.
Likely candidates for negative regulators of the IFN-ab production
are the E1A proteins. Previously, they were shown to inhibit Stat1
signal transduction [86], which plays a role in positive feedback
signaling by means of the IFN-ab receptor.
Adenoviruses, toxic effects and therapeutic applications
Because the adenoviral vectors used in this study correspond to
some of those used in gene therapy trials, the present findings in
mice may have important implications for Ad gene therapy
applications. The adverse effects observed in therapeutic trials,
such as systemic inflammatory response and toxicity [6,7,9] can be
at least partly explained by the enhanced susceptibility of the Ad-
infected host to microbial components, such as LPS [72] and
lipopeptides (unpublished results) from incoming secondary
pathogens or from the patient’s own flora. Our in vitro finding of
a strongly enhanced TNF-a response to LPS in Ad5-GFP-infected
human DCs suggests that enhanced susceptibility to LPS may
develop also in patients treated with adenoviral vectors. As shown
here, this hypersensitivity is mediated by viral-induced IFN-ab,
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which is in accordance with the role of IFN-ab as a key mediator
of sensitization to LPS [87,88]. The increased mCD14 expression
on LPS target cells and epigenetic changes on promoters of
relevant genes (both shown here), may at least in part explain the
role of IFN-ab in the development of Ad induced LPS
hypersensitivity.
Type I interferon induction was recently found in recombinant
Ad-treated human cells, especially in pDCs [46,89] and in
monocyte-derived DCs in the present study. Moreover, this
response was observed also in patients administered with
recombinant adenoviral vectors [42,90]. Since as shown here,
IFN-a pre-treatment is capable of increasing susceptibility to LPS
of human DCs in vitro, we assume that Ad-induced IFN-ab can
induce LPS hypersensitivity in humans in vivo. Undesirable
complications mediated by IFN-ab can occur not only during
gene therapy, but also in immunocompromised patients where
Ads are major pathogens [1]. Our finding that blocking SAPK/
JNK signaling inhibits the IFN-ab response to Ads, is of potential
interest for prevention or treatment of the direct and indirect
adverse effects of IFN-ab in Ad gene therapy.
Materials and Methods
Mouse strains
Wt C57BL/6, C57BL/10 and 129Sv mice, as well as all
knockout mice were bred under SPF conditions at the MPI.
Breeding pairs of IRF-32/2 and IRF-72/2 mice were kindly
provided by T. Taniguchi and K. Honda, (Department of
Immunology, Graduate School of Medicine, University of Tokyo,
Tokyo), of the TRIF and Unc 93B2/2 mice by B. Beutler (Scripps
Research Institute, La Jolla) and of MyD882/2 mice by M. Kopf
(TH Zu¨rich) and R. Landmann (Department Forschung, Kanton-
spital Basel). MDA-52/2 femurs were provided by M. Colonna
(Washington University School of Medicine, St. Louis). IRF-3-
[30], IRF-7- [29], Myd88- [91], TRIF- [92], TLR-9- [93], Unc
93B [94] MDA-5 [25] deficient mice and CD11c-diphtheria toxin
receptor (DTR)/GFP transgenic mice [54] were on a C57BL/6
background, TLR2/4-deficient mice [95] on C57BL/10 back-
ground and IFNabR-deficient mice [96] on 129Sv and for the
lethality experiments on C57BL/6 background. When the strain
of the mouse was not indicated C57BL/6 mice were used. Mice of
both sexes, 8-12 weeks of age were used for the experiments. All of
the experimental procedures were in accordance with institutional,
state and federal guidelines on animal welfare.
Viruses
Human Ads of species B (Ad serotype 3) and C (Ad R700, an
Ad serotype 5 derivative, Ad serotype 2, Ad2Ts1 and Ad5-GFP an
early gene expression defective Ad were grown, purified and
stored as previously described [5,72]. The ratio of infectious/total
viral particles was determined on susceptible cells and was typically
1:20–50. If not otherwise stated, Ad2Ts1 used for the experiments
was grown at non-permissive temperature 38.5uC (resulting in the
absence of incorporation of the adenoviral protease L3/23 into
viral capsids). Empty particles were identified by their light density
in CsCl density gradients and the absence of viral DNA and were
purified simultaneously with mature virions. UV inactivation of
Ad was done as described previously [5,72] using the minimal
essential dose preventing viral gene expression and replication in
susceptible cells. Heat inactivation was done at 56 uC for 60 min
[44]. All virus preparations were LPS-free (less than 1 pg LPS/
1011 viral particles) as determined by the Limulus amebocyte
lysate test (Pyroquant Diagnostic GMBH, Mo¨rfelden, Germany).
Cell culture, inhibitors, plasmids and transfection
MEFs, BMMs and GM-CSF induced BMDCs were generated
as described [95,97]. The purity of BMMs was higher than 98%,
of BMDCs approximately 80%. BM derived pDCs were generated
in the presence of Flt3L and CD11c+ CD11b2 B220+ CD62L+
pDCs were MoFlo sorted (purity higher than 95%) as described
[55]. MEFs were grown in a-MEM (Invitrogen). Immature,
monocyte derived human DCs were obtained by incubating
adherent monocytes with GM-CSF as described [98] Human
mDCs were infected with the indicated amounts of Ads in growth
medium containing 2% of donor serum. Mouse L-929 cells were
grown in DMEM with 10% FCS. MAPK inhibitors UO126
(MEK1/2, Cell Signaling), SB203580 (p38, Sigma) and SP600125
(SAPK/JNK Calbiochem) were used at 15 mM in vitro and
SP600125 at 20 mg/kg in vivo. Bafilomycin-A1 (Sigma) was used at
100 nM. The plasmids pmaxGFP (Amaxa) and RIG-IC
[64,99,100] were purified with the Endo-Free Plasmid kit (Qiagen)
and PEG purification. RV leader RNA was generated by in vitro
transcription (MEGA shortscript Kit; Ambion) from a synthetic
DNA template: 59ACATTTTTGCTTTGCAATTGACAATGT-
CTGTTTTTTCTTTGATCTGGTTGTTAAGCGTTATAGT-
GAGTCGTATTACGCG-39 annealed with 59-AATTCGCG-
TAATACGACTCACTATA-39. RNA was purified using mini
Quick Spin RNA Columns (Roche). siRNA mediated knockdown
of DAI/Zbp1 was done using DAI/Zbp1 targeting siRNAs (On-
Target Plus Smartpool reagent, Dharmacon). For the induction of
type I IFNs MEFs and BMDCs were transfected with nucleic acids
complexed with Lipofectamine 2000 (Invitrogen) in 96-well plates
according to the instructions of the manufacturer. L-929 cells were
cotransfected with siRNAs and pmaxGFP using Lipofectamine
2000 according to the suggestions of the supplier. Subsequently
GFP positive cells were purified by FACS sorting for further
analysis. BMDCs were co-transfected with siRNAs or RIG-IC
together with pmaxGFP using the nucleoporator apparatus and
the mouse dendritic cell nucleofector kit (Amaxa) according to the
suggestions of the supplier and gene expression was analyzed in
FACS-sorted GFP positive cells.
Spleen cell fractionation, FACS sorting and depletion of
DC subsets
Splenocytes of 3–5 spleens were separated into CD11c+ and
CD11c2 cells by magnetic adsorption cell sorting (MACS;
Miltenyi Biotec). Both fractions were further purified by FACS
sorting using anti CD11c-biotin and Streptavidin-PE-Cy5 (BD
PharMingen). For the analysis and isolation of splenocytes and
CD11c+ subsets, anti-CD11c-biotin, anti-mouse CD11b-Alexa
Fluor 647, Gr-1 FITC, B220 PE, F4/80 PE, anti-mouse CD14-
Alexa Fluor 647 and anti-mouse TLR4/MD2-Alexa Fluor 647
antibodies and Streptavidin-PE-Cy5 (BD PharMingen) and anti-
Siglec H-biotin from Hycult Biotechnology were used. 4–
206104 cells in the different fractions were sorted using MoFlo
(Dako Cytomation, Glostrup,) to a typical purity of 95%–97%. To
deplete mDCs, CD11c-DTR/GFP mice were injected i.p. with
DT (4 ng/g body weight; Sigma-Aldrich) as described. pDCs were
depleted from naı¨ve mice with 500 mg i.p. injected rat anti–
mPDCA-1 mAb (Miltenyi Biotec) 24 h prior to Ad infection.
Detection of secreted cytokines and intracellular proteins
Murine IFN-ab activity was measured using an L-929 cell line
(provided by B. Beutler and Z. Jiang, Scripps Research institute,
La Jolla) as described [18] Human IFN-ab bioactivity was
measured using the HL116 cells from G. Uze´ as described
[101]. The contribution of IFN-a or IFN-b to the total IFN-ab
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activity was determined by pre-incubating plasma for 1 h with
excess amounts of neutralizing anti–IFN-b antibody (Yamasa
Corporation, Japan) or control antibody. Murine TNF-a was
measured by a bioassay as described [95]. IL-6 was detected with
an ELISA from Pharmingen BD. Human TNF-a was detected
with an ELISA from R&D Biosystems. JNK/SAPK MAPKs were
detected on immunoblots with antibodies detecting all or
phosphorylated isophorms of the proteins (Cell Signaling).
Zbp1/DAI and b-actin were detected on immunoblots with
antibodies from Santa Cruz Biotechnology.
Conventional RT-PCR, real-time RT-PCR, analysis of IFN-a´aˆ
subtypes and Chromatin Immunoprecipitation
Total RNA was isolated from organs and cells with guanidi-
nium-thiocyanate-phenol-chloroform extraction or with TRI
reagent (Sigma). To exclude DNA contamination, RNA samples
were treated with RNase free DNase I (Fermentas). cDNA was
prepared using Expand reverse transcriptase (Roche) and oligo-
dT. Conventional RT-PCRs were performed with primers as
follows. b-actin: GTC CAC ACC CGC CAC CAG TTC G and
GGA ATA CAG CCC GGG GAG CAT CGT C, IFN-b: CCT
TTG CAC CCT CCA GTA ATA G and GAC GGA GAA GAT
GCA GAA GAG T, IFN-a: ATG GCT AGR CTC TGT GCT
TTC CT and AGG GCT CTC CAG AYT TCT GCT CTG,
Ad2 E1A: GTT ATT ACC GAA ATG GCC GCC AGT CT and
CTT CGG GGG CCG TCA CGT CTA AAT CAT AC.
Real-time PCR quantification of RNA expression was done
using the LightCycler II system (Roche) and the Quantitect SYBR
Green PCR Kit (Qiagen) according to the instructions of the
manufacturers. Arbitrary units of relative expression were
generated by dividing the value obtained for IFN-a, -b or IL-6
by the value of b-actin and multiplying the result by 1000. The
detection limits for the IFN-a and IFN-b PCRs were 150 and 30
copies/reaction, respectively. The following primers were used for
real-time RT-PCR: b-actin: TGG AAT CCT GTG GCA TCC
ATG AAA and TAA AAC GCA GCT CAG TAA CAG TCC G,
IFN-b: CCT TTG CAC CCT CCA GTA ATA G and GAC
GGA GAA GAT GCA GAAGAG T, IFN-a: TCT GAT GCA
GGT GGG and AGG GCT CTC CAG ACT TCT GCT CTG,
IL-6: GTG ACA ACC ACG GCC TTC CCT AC and TGC
AAG TGC ATC ATC GTT GTT CAT, Zbp1/DAI: GAC GAC
AGC CAA AGA AGT GA and GAG CTA TGT CTT GGC
CTT CC. The IFN-a primers are consensus sequences from
previous publications [102,103], detecting all IFN-a mRNAs. To
determine the levels of different IFN-ab subtypes the HT7900
quantitative PCR system (Applied Biosystems) was used. cDNAs
were measured in duplicates or triplicates using the following gene-
specific assays (TaqMan Gene Expression Assays, Applied
Biosystems): IFN-alpha2 (Mm00833961_s1), IFN-alpha4
(Mm00833969_s1), IFN-alpha5 (Mm00833976_s1), IFN-alpha6
(Mm02524285_g1), IFN-alpha9 (Mm00833983_s1), IFN-alpha11
(Mm01257312_s1), IFN-alpha12 (Mm00616656_s1), IFN-al-
pha13 (Mm00781548_s1), IFN-alpha14 (Mm01703465_s1),IFN-
beta (Mm00439546_s1). The gene for mouse hypoxanthine
guanine phosphoribosyl transferase-1 (HPRT-1,
Mm00446968_m1) was used to calibrate the mRNA levels.
Quantitative analysis was performed using the SDS 2.1 software
(Applied Biosystems). mRNA levels were calculated by the
following formula: relative expression = 2‘(2(Ct(Target)-Ct(En-
dogenous control))*f, with f = 10 000 as an arbitrary factor.
Chromatin Immunoprecipitation (ChIP) assays were performed
as described [104]. Briefly, cells were cross-linked with 1%
formaldehyde and sonicated nuclear extracts were mock-immu-
noprecipitated or immunoprecipitated with anti-tetraacetylated
histone H4 (Upstate). Recovered DNA aliquots from these samples
and from input extracts were amplified with real-time PCR using
the LightCycler II system (Roche) and Quantitect SYBR Green
PCR Kit (Qiagen). Enrichments at specific chromatin loci are
shown as the amount of immunoprecipitated DNA in the percent
of total input chromatin. The following primers were used: IL-6
promoter: TGG GGA TGT CTG TAG CTC ATT and CAT
AGC GGT TTC TGG AAT TGA, TNF promoter: GGG CAG
CCC CAG AGG GAA TGA ACT C and TAT GGC AGA GGC
TCC GTG GAA AAC TCA CT, Topoisomerase 3b promoter:
AGT CCG AGA ACA GCC TGG GT and AGT TGT GCT
GCC CAC AGA GG, l5 promoter: TCC CCA TTG CCA GAT
AGA GAC ACA and TGG GCC CAA CAG ATT AAC ACA
GAG.
Transmission electron microscopy
BMDCs were cold synchronized with saturating amounts of
Ad2 and Ad2-ts1 (60 mg/ml, 0.25 ml per 46104 cells on a 12 mm
glass coverslip) for 1 h, washed and incubated at 37uC for the
indicated times. The samples were fixed with 2.5% glutaraldehyde
in 0.1 M ice-cold Na-Cacodylate buffer (pH 7.2) containing
0.5 mg/ml ruthenium red for 1 h, washed with 0.1 M Na-
Cacodylate buffer (pH 7.2), post-fixed with 2% OsO4 in the same
buffer containing 0.5 mg/ml ruthenium red for 1 h at room
temperature, and embedded in Epon as described [105]. Virus
particles at the plasma membrane, endosomes and the cytosol
were determined, and results expressed as means of analyzed cells
(n) with standard errors of the mean.
Data analysis and statistics
Data was analyzed using Prism GraphPad 4.0 software. Data in
all figures are presented as mean, error bars show SEM. Statistical
analysis was performed with the unpaired t-test (*: P,0.05; **:
P,0.01; ***: P,0.005).
List of accession numbers/ID numbers for proteins
mentioned in the text
1. DEFINITION interferon-beta.
ACCESSION AAA72488
2. DEFINITION interleukin 6 [Mus musculus].
ACCESSION NP_112445
3. DEFINITION tumor necrosis factor [Mus musculus].
ACCESSION NP_038721
4. DEFINITION CD14 [Mus musculus].
ACCESSION CAA32166
5. DEFINITION toll-like receptor 9 [Mus musculus].
ACCESSION NP_112455
6. DEFINITION toll-like receptor 4 [Mus musculus].
ACCESSION NP_067272
7. DEFINITION toll-like receptor 2 [Mus musculus].
ACCESSION NP_036035
8. DEFINITION MyD88 [Mus musculus].
ACCESSION AAC53013
9. DEFINITION TRIF [Mus musculus].
ACCESSION BAA76376
10. DEFINITION interferon induced with helicase C domain 1
(MDA-5) [Mus musculus].
ACCESSION NP_082111
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11. DEFINITION DEAD/H box polypeptide RIG-I [Mus
musculus].
ACCESSION NP_766277 XP_990501
12. DEFINITION Z-DNA binding protein 1 [Mus musculus].
ACCESSION NP_067369
Supporting Information
Figure S1 IFN-ab induction in response to Ads. Induction
kinetics of IFN-ab in the plasma of B6 mice (4–6/group) after the
indicated time-points of i. p infection with 3.661010 viral particles
of intact Ad R700. 6 h and 8 h values were analyzed for statistical
significance using the unaired t-test. (A). Control of UV
inactivation of Ads. B6 mice were infected intraperitoneally with
Ad3 or UV inactivated Ad3 and 1.261010 particles/mouse and
the expression of Ad E1A mRNA was measured in the spleen and
liver 16 h after infection. BMDCs were infected with native or
inactivated Ad in vitro with (5400 particles/cell) and analyzed for
E1A mRNA expression 8 h after infection (B). BMDCs were
infected in vitro with Ad5 GFP and UV inactivated Ad5 GFP
(5400 particles/cell). The expression of GFP was controlled by
FACS analysis 16 h after infection (C).
Found at: doi:doi:10.1371/journal.ppat.1000208.s001 (311 KB
TIF)
Figure S2 IFN-ab and IL-6 induction in response to Ads. Kinetics
of the IFN-ab response to UV inactivated Ad R700 (A) or Ad5 GFP
(B) in B6 mice. Groups of B6 mice (4–6/group) were infected i.p. with
3.661010 viral particles or of UV inactivated Ad R700 (A) or Ad5
GFP (B) and plasma for IFN measurement was collected at the
indicated time-points. IFN-ab and IL-6 responses to graded doses of
Ad R700. B6 mice (4–6/group) were infected with 46109 (1),
1.261010 (2), 3.661010 (3) and 7.261010 (4) of native (empty bars) or
UV-inactivated (filled bars) Ad R700 viral particles/mouse, i.p. Mice
were bled 6 hours after infection and the levels of IFN-ab (C) and IL-
6 (D) in plasma were determined. Representative experiments of two
are shown. Effiect of heat inactivation on Ad entry. BMDCs from B6
mice were infected with native or heat inactivated Ad3 (5400
particles/cell) and the presence of internalized Ad DNA was detected
with PCR 16 h later (E) in nuclear extracts as described [66].
Found at: doi:doi:10.1371/journal.ppat.1000208.s002 (203 KB
TIF)
Figure S3 Induction of IFN-ab in pDCs and in human DCs.
IFN-ab response of in vitro generated mouse mDC and pDC to
Ad3. BM derived GM-CSF- induced mDCs and FLt3L-induced
pDCs generated from B6 mice were mock-infected or infected
with 600, 1800 and 5400 viral particles of Ad3/cell. Cell-free
supernatants for IFN-ab measurement were collected 16 h after
infection (A). Absence of IFN-ab induction in L-929 cells by Ad.
L-929 cells were infected with 1800 and 5400 Ad2 particles/cell or
left uninfected. IFN-ab was measured in cell-free supernatants
16 h after infection (B, left). The expression of E1A and b-actin
mRNAs was measured 16 h after Ad2 infection by RT-PCR (B,
right). IFN-ab response of human primary DCs to Ad. Human
monocyte derived DC were mock-infected or infected with of Ad5
GFP or Ad3 (16 200 particles/cell). IFN-ab was measured in cell-
free supernatants 24 h after infection. (C)
Found at: doi:doi:10.1371/journal.ppat.1000208.s003 (181 KB
TIF)
Figure S4 Purification and analysis of lymphocyte subsets in the
spleen of Ad infected mice. Groups of B6 mice (4–6/group) were
infected i.p. with 3.661010 viral particles of Ad3 and spleens for
analysis were removed 8 h after infection. Pooled splenocytes were
analyzed with the respective antibodies by FACS. Gates used for
the analysis and purification of splenocytes and DC subsets are
shown for representative samples. FACS sorting of DC subsets (A–
D) To isolate pDCs, CD11c+ MACS enriched cells were
subdivided as CD11cint, CD11b2 cells (A) and then Gr-1+,
B220+ (B) cells. mDCs were isolated from CD11c+ cells (A) as
CD11b+, Gr-12 cells (C). From CD11c+, CD11b2 cells (C) a F4/
80+ subpopulation was obtained (D).
Found at: doi:doi:10.1371/journal.ppat.1000208.s004 (252 KB
TIF)
Figure S5 Analysis of DC depletion after diphteria toxin (DT)
treatment in the spleen of CD11c-DTR and B6 mice. CD11c-
DTR and B6 mice (4 animals/group) were injected with DT i. p or
left untreated. 24 h later the animals were infected with 1.261010
viral particles of Ad3 and DC populations in splenocytes from
individual animals were analyzed with flow cytometry using the
indicated antibodies. The percentage of the respective population
in a representative animal is given in the plot panels (A–B).
Found at: doi:doi:10.1371/journal.ppat.1000208.s005 (704 KB
TIF)
Figure S6 Analysis of pDC depletion after anti mPDCA-1
antibody treatment. Mice were untreated (2aPDCA-1; 4
animals/group) or injected with 500 mg of anti-mPDCA-1
antibody (+aPDCA-1; 4 animals/group) injected with Ad3 and
the pDC (A) and mDC (B) populations were analyzed in
splenocytes of individual mice with flow cytometry. Representative
data for one mouse/group are shown.
Found at: doi:doi:10.1371/journal.ppat.1000208.s006 (524 KB
TIF)
Figure S7 Intracellular TLR signaling is not required for Ad5-
GFP induction of IFN-ab. Wt and TLR9 2/2 or Unc93B 2/2
mice (4 animals/group) were infected with 161010 Ad5 GFP
particles i. p. and IFN-ab was determined in plasma 6 h after
infection (A). Cytokine response of various TLR deficient mice to
TLR ligands. Wt, TLR9, MyD88, TRIF and TLR2/4 deficient
mice were challenged with 10 nmol CpG ODN 1668 or with 1 mg
of LPS i.p. as indicated. IFN-ab was measured in plasma 2 h after
stimulation (B, left). Wt and TLR2/4 deficient mice were injected
with 40 mg of lipopeptide i. p. (Pam3CysK4) and plasma TNF-a
levels were measured 2 h after challenge (B, right).
Found at: doi:doi:10.1371/journal.ppat.1000208.s007 (162 KB
TIF)
Figure S8 Role of IFN-ab feedback signaling in Ad-infected
BMDCs. BMDCs from wt and IFNabR 2/2 mice were mock-
infected or infected with 600, 1800 and 5400 Ad3 particles/cell.
IFN-ab was measured in cell-free supernatants 16 h after
infection. One representative experiments of three is shown.
Found at: doi:doi:10.1371/journal.ppat.1000208.s008 (75 KB
TIF)
Figure S9 IRF-7 but not IRF-3 is required for Ad5GFP induced
IFN-ab production in vivo. Wt, IRF-3 and IRF-7 deficient mice
were injected with 161010 particles of Ad5 GFP i. p. and plasma
IFN-ab levels were measured 6 h after infection.
Found at: doi:doi:10.1371/journal.ppat.1000208.s009 (98 KB
TIF)
Figure S10 Knock-down of DAI/Zbp1 in L-929 cells. L-929
were transfected with pmaxGFP alone (4 mg DNA/1.66106 cells)
or together with DAI/Zbp1 targeting siRNAs (4 mg DNA and
200 pmol siRNA/1.66106 cells) with Lipofectamine 2000. Forty-
two hours later the cells were stimulated with B-DNA: poly(dA-
dT)?poly(dT-dA) (2 mg/ml) complexed with Lipofectamine 2000
Innate Immune Response to Adenovirus
PLoS Pathogens | www.plospathogens.org 18 November 2008 | Volume 4 | Issue 11 | e1000208
for 6 hrs or left unstimulated and GFP+ cells were purified with
FACS-sorting. Knockdown of DAI/Zbp1 mRNA (A) and protein
(B) was measured with real-time RT-PCR and with immunoblot-
ting, respectively. Expression of IFN-b mRNA was measured with
real-time RT-PCR (C).
Found at: doi:doi:10.1371/journal.ppat.1000208.s010 (179 KB
TIF)
Figure S11 Adenovirus induced IL-6 production is dependent
on JNK signaling. BMDC cultures from B6 mice were pretreated
with the indicated MAPK inhibitors or with diluent for 15 min
and then infected with 1800 and 5400 viral particles of Ad3/cell or
were mock infected. IL-6 levels were measured from cell-free
supernatants taken 6 h after infection. A representative experi-
ment of three is shown.
Found at: doi:doi:10.1371/journal.ppat.1000208.s011 (108 KB
TIF)
Figure S12 The role of viral endosomal escape in adenovirus
triggered cytokine responses. Empty Ad particles do not induce
type I IFN in vivo. B6 mice (4/group) were infected with 1.261010
viral particles of mature Ad3 and with an equivalent dose of empty
Ad3 particles. Plasma samples were taken 8 hours after infection
and the levels of IFN-ab were measured (A). Comparison of the
induction of IL-6 of mice infected with wild-type Ad2 or the
endosomal escape deficient Ad2Ts1 virus. B6 Mice (4/group) were
infected with 3.661010 Ad2 or Ad2Ts1 grown at 38.5uC (Ts1), i.
p. IL-6 was measured 4 and 8 h after infection in plasma samples.
(B) Comparison of the cytokine responses of BMDCs infected with
Ad2 or Ad2Ts1 (Ts1). BMDCs from B6 mice were infected with
1800, 5400, and 16 200 particles of Ad2/cell or with 32 400
particles of Ts1/cell or were mock-infected. IFN-ab (C) and IL6
(D) were measured in cell-free supernatants 16 h after infection.
Comparison of Ad vector and Ad2Ts1 induced IFN-ab produc-
tion of human monocyte derived DCs. Cells were infected with
16 200 particles of Ad5 GFP or Ad2 Ts1/cell or were mock-
infected. IFN-ab was measured in cell-free supernatants 24 h after
infection (E).
Found at: doi:doi:10.1371/journal.ppat.1000208.s012 (175 KB
TIF)
Figure S13 Bafilomycin A1 inhibits Ad3 triggered IFN-ab and
IL-6 production in vitro. BMDC cultures derived from C57BL/6
mice were pretreated with the 100 nM bafilomycin A1 (black bars)
or with diluent (empty bars) for 15 min and then infected with
1800, 5400, and 16 200 viral particles of Ad3/cell or were mock
infected. IFN-ab (A) and IL-6 (B) levels were measured from the
cell-free supernatants taken 6 h after infection. Representative
experiments of three are shown.
Found at: doi:doi:10.1371/journal.ppat.1000208.s013 (127 KB
TIF)
Figure S14 Adenovirus triggered LPS hypersensitivity. Low
doses of Ads can induce LPS hypersensitivity. B6 mice (3/group)
were infected with 56108 (1) or 56109 (2) particles of Ad5 GFP or
left uninfected. Expression of IFN-b in spleen and plasma IFN-ab
was measured using RT-PCR and bioassay, respectively (A). In a
separate experiment mice were infected as described above and
16 h later challenged with 1 mg of LPS i. p. TNF-a levels were
measured in plasma 2 h later. (B). Ad infection and IFN-a
treatment augments LPS induced TNF-a production of human
DCs. Human monocyte derived DCs were mock-treated, or pre-
infected with Ad5 GFP or Ad3 (16 200 particles/cell) or pre-
treated with 50 U/ml hIFN-a. 16 h later the cells were stimulated
with 1 mg/ml LPS overnight. TNF-a was measured in cell-free
supernatants (C). Ad infection increases minimally the expression
of TLR4/MD2 on splenic macrophages. Wt and IFN-abR 2/2
mice were infected with 161010 Ad5 GFP particles i. p. or left
uninfected. Expression of TLR4/MD2 was measured on the
surface of F4/80+ splenic macrophages by FACS 16 h after
infection (D).
Found at: doi:doi:10.1371/journal.ppat.1000208.s014 (335 KB
TIF)
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